Organization
Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France
4 abstracts
Abstract
LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis.Org: Centre Hospitalier Universitaire, Limoges, France, Office of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France, Centre Eugène Marquis, Rennes, France, Centre Antoine Lacassagne, Nice, France,
Abstract
Training and validation of a model predicting clusters of long-term cancer-related behavioral symptoms (CRBS) after breast cancer (BC).Org: INSERM Unit 981, Gustave Roussy Département d'Organisation du Parcours Patient, Villejuif, France, Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France, Institut Curie, Saint Cloud, France,
Abstract
Long-term longitudinal patterns of patient-reported quality of life (QOL) after breast cancer (BC) to inform the implementation of personalized pathways of care.Org: Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy Département d'Organisation du Parcours Patient, Villejuif, France, Breast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France,
Abstract
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).Org: IRCCS Ospedale Policlinico San Martino, Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, UOC Oncologia Medica,